Literature DB >> 28936998

Venous thromboembolism due to hyperhomocysteinaemia and tuberculosis.

Ankush Chaudhary1, Unnati Desai1, Jyotsna M Joshi1.   

Abstract

An 18-year-old male presented to our hospital with complaints of episodic abdominal pain, dry cough and right pleuritic chest pain. He was diagnosed as a case of right tuberculous pleural effusion on the basis of the pleural fluid Genexpert report of Mycobacterium tuberculosis detected sensitive to rifampicin and was started on antituberculous therapy. Forty-five days later, he presented with acute onset breathlessness, swelling of the right leg, streaky haemoptysis and a fresh left-sided pleural effusion. Evaluation revealed venous thromboembolism (right lower lobar segment pulmonary embolism with right leg deep vein thrombosis). Workup for malignancy was negative. However, he had vitamin B12 deficiency with increased homocysteine levels and heterozygous mutation of the MTHFR gene at A1298C. He was treated with optimal anticoagulation, vitamin B12 supplementation and antitubercular treatment. This is a rare combination of events perhaps related to the MTHFR gene mutation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28936998

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  3 in total

1.  Pulmonary embolism and megaloblastic anemia: is there a link? A case report an literature review.

Authors:  Grecia Iveth Raymundo-Martínez; Rodrigo Gopar-Nieto; Gonzalo Carazo-Vargas; Diego Araiza-Garaygordobil; Sergio Raul Scuri; Laura Leticia Rodríguez-Chavez; Nilda Espinola-Zavaleta
Journal:  Radiol Case Rep       Date:  2018-09-14

2.  Epidemiology of venous thromboembolism in people with active tuberculosis: a systematic review and meta-analysis protocol.

Authors:  Philippe Armel Awana; Celestin Danwang; Joel Noutakdie Tochie; Jean Joel Bigna
Journal:  BMJ Open       Date:  2019-11-12       Impact factor: 2.692

3.  Toxicoproteomic Profiling of hPXR Transgenic Mice Treated with Rifampicin and Isoniazid.

Authors:  Christopher Trent Brewer; Kiran Kodali; Jing Wu; Timothy I Shaw; Junmin Peng; Taosheng Chen
Journal:  Cells       Date:  2020-07-09       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.